Wednesday, 21 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14691
Articles
Company
Drug
Zelgen’s Jakitinib Phase III Study Meets Primary Endpoint for Myelofibrosis
March 25, 2025
Company
Deals
Nanjing CRO Caremo Secures RMB 150 Million in Series A Round
March 25, 2025
Company
Drug
Lee’s Pharmaceutical Wins NMPA Approval for ALS Drug Teglutik
March 25, 2025
Company
Deals
Winsan Medical Acquires 52% Stake in Goodfeel Dental Clinic for RMB 156 Million
March 25, 2025
Company
Drug
InnoCare Pharma’s ICP-189 First Dosed in China SHP2 Inhibitor Trial
March 25, 2025
Company
Deals
China NT Pharma Group Inks Licensing Deal for Orticumab in Asia
March 25, 2025
Company
Deals
Mega Genomics Limited Makes Hong Kong IPO Debut at HKD 18 Per Share
March 25, 2025
Company
Medical Device
Venus Medtech’s VenusP-Valve Used Compassionately in US for Pulmonary Regurgitation
March 25, 2025
Company
Drug
Merck KGaA’s Erbitux Approved in China for Head and Neck Cancer Treatment
March 25, 2025
Company
Drug
CSPC’s JMT103 Accepted for Review in China, Targets RANKL-Related Deficiencies
March 25, 2025
Company
Medical Device
Grand Pharma Launches SIR-Spheres for Liver Cancer Treatment in China
March 25, 2025
Policy / Regulatory
R&D
Beijing Introduces White List System for Biomedical R&D Item Imports
March 25, 2025
1
2
…
1,213
1,214
1,215
1,216
1,217
…
1,224
1,225
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?